PINK:XSNX

Xsunx Stock Company Profile

Healthcare > Biotechnology

Buy XSNX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jul 31, 2026

Information

8834 Mayfield Road, Suite C

Chesterland OH 44026

440 644 1027

novaccessglobal.com

Industry: Biotechnology

Sector: Healthcare

Description

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.

GOLDEN STAR

Ticker	Change	Signal Date
FOX $50.81	2.22%	Jul 27
UNFI $49.05	3.63%	Jul 27
BIIB $202.19	0.376%	Jul 24
TSCO $30.32	1.48%	Jul 23
S SW $43.71	5.17%	Jul 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by